Same Name, Different Chemical: The Hidden Salt-Form Trap in Peptide Testing

FDA’s July 2026 peptide briefing documents expose a critical testing issue: a common peptide name may not identify its salt form, assay basis, or true peptide content.

FDA’s July 2026 peptide briefing documents expose a critical testing issue: a common peptide name may not identify its salt form, assay basis, or true peptide content.